M. Toyoda

发表

Regulation of Anti-HLA Antibody-Dependent Natural Killer Cell Activation by Immunosuppressive Agents

S. Jordan, J. Mirocha, B. Shin, 2014, Transplantation.

Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient

S. Jordan, N. Silverman, A. Vo, 2005, Transplant infectious disease : an official journal of the Transplantation Society.

Polyomavirus BK Viremia in Kidney Transplant Recipients After Desensitization With IVIG and Rituximab

S. Jordan, J. Mirocha, N. Reinsmoen, 2013, Transplantation.

Advances in diagnosing and managing antibody-mediated rejection

S. Jordan, N. Reinsmoen, A. Vo, 2010, Pediatric Nephrology.

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation

C. Nast, M. Haas, K. Wood, 2017, The New England journal of medicine.

Use of Rituximab for persistent EBV DNAemia, and Its effect on donor‐specific antibody development in pediatric renal transplant recipients: A case series

E. Kamil, S. Jordan, N. Reinsmoen, 2021, Pediatric transplantation.

A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

M. Haas, S. Jordan, N. Reinsmoen, 2015, Transplantation.

Clazakizumab for desensitization in highly sensitized patients awaiting transplantation

M. Haas, S. Jordan, Xiaohai Zhang, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejection.

C. Nast, S. Jordan, M. White, 2015, Transplant immunology.

IFNγ production by NK cells from HLA-sensitized patients after in vitro exposure to allo-antigens.

S. Jordan, P. Pichurin, B. Shin, 2012, Transplant immunology.

B-cell immunotherapeutics: emerging roles in solid organ transplantation

S. Jordan, A. Vo, M. Toyoda, 2011, Current opinion in organ transplantation.

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

D. Stablein, D. Milliner, G. Ciancio, 2004, Journal of the American Society of Nephrology : JASN.

PROLONGATION OF ALLOGRAFT SURVIVAL WITH VIRAL IL-10 TRANSFECTION IN A HIGHLY HISTOINCOMPATIBLE MODEL OF RAT HEART ALLOGRAFT REJECTION1

A. Trento, S. Jordan, M. Toyoda, 2001, Transplantation.

The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation.

D. Freimark, L. Czer, A. Trento, 1999, Transplantation.

Prolongation of skin allograft survival is associated with reduced Th1 cytokine responses in the WKY-->F344 rat model.

A. Marchevsky, J. Matloff, S. Jordan, 1999, Transplantation.

Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization.

N. Chai, S. Jordan, J. Mirocha, 2010, Transplant immunology.

Liver Transplantation in a Patient With CD40 Ligand Deficiency and Hyper‐IgM Syndrome: Clinical and Immunological Assessments

B. Shin, S. Ge, M. Toyoda, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prolongation of cardiac allograft survival with intracoronary viral interleukin-10 gene transfer.

L. Czer, A. Trento, S. Jordan, 1999, Transplantation proceedings.

Pooled Human Gammaglobulin Modulates Surface Molecule Expression and Induces Apoptosis in Human B Cells

S. Jordan, M. Toyoda, A. Pao, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis

S. Jordan, M. Toyoda, B. Bloom, 2007, Rheumatology International.

Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy.

M. Fishbein, C. Blanche, L. Czer, 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection.

S. Jordan, M. Toyoda, A. Petrosian, 1999, Transplantation.

Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients.

L. Czer, S. Jordan, M. Toyoda, 1997, Transplant immunology.

Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage.

A. Marchevsky, A. Bagga, S. Jordan, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Significant Reduction of ATP Production in PHA-Activated CD4+ Cells in 1-Day-Old Blood from Transplant Patients

L. Czer, S. Jordan, J. Mirocha, 2012, Transplantation.

Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction.

S. Jordan, M. Toyoda, R. Radha, 2010, Transplant immunology.

Metabolic and Hematologic Effects and Immune Complex Formation Related to Pertussis Immunization

M. Knip, J. Cherry, M. Uhari, 1990, Pediatric Research.

Development of CMV‐specific cytotoxic T cells (CMV‐Tc) in pediatric renal transplant recipients with CMV viremia

S. Jordan, M. Toyoda, E. Huang, 2021, Pediatric transplantation.

Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant Patients

A. Sinha, S. Jordan, S. Ge, 2017, Transplantation.

Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients

S. Jordan, J. Mirocha, B. Shin, 2017, Journal of immunology research.

Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA‐Sensitized Patients

S. Jordan, D. Tyan, A. Vo, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Current approaches to treatment of antibody‐mediated rejection

C. Nast, S. Jordan, D. Tyan, 2005, Pediatric transplantation.

Post‐transplant therapy with high‐dose intravenous gammaglobulin: Applications to treatment of antibody‐mediated rejection

C. Nast, S. Jordan, D. Tyan, 2005, Pediatric transplantation.

Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

S. Jordan, N. Reinsmoen, A. Vo, 2010, Transplantation.

Decreased gamma-IFN and IL-2 gene expression in regional lymph nodes of skin allografts is associated with increased allograft survival in the WKY F344 rat model.

A. Marchevsky, J. Matloff, S. Jordan, 1999, Transplantation proceedings.

JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen‐sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab

J. Mirocha, S. Ge, A. Vo, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Exogenous interleukin-2 does not reverse the immunoinhibitory effects of 1,25-dihydroxyvitamin D3 on human peripheral blood lymphocyte immunoglobulin production.

J. Adams, S. Jordan, M. Toyoda, 1990, Molecular immunology.

1,25 dihydroxyvitamin-D3 regulation of immunoglobulin production in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

S. Jordan, J. Klinenberg, M. Toyoda, 1989, Journal of autoimmunity.

41 – Transplant Immunology

S. Jordan, M. Toyoda, 2010 .

Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.

M. Kehry, Gordon D. Wu, N. Chai, 2008, Transplant immunology.

Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts

M. Haas, S. Jordan, Xiaohai Zhang, 2022, Kidney international reports.

1,25-Dihydroxyvitamin-D3 regulation of interleukin-2 and interleukin-2 receptor levels and gene expression in human T cells.

J. Adams, S. Jordan, J. Prehn, 1989, Molecular immunology.

Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab.

N. Chai, S. Jordan, J. Mirocha, 2011, Transplant immunology.

Pre-transplant donor-specific transfusions induce allograft rejection and IL-2 gene expression in the WKY-->F344 functional tolerance model of rat lung transplantation.

A. Marchevsky, J. Matloff, S. Jordan, 1998, Transplant immunology.

Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients.

L. Czer, S. Jordan, D. Tyan, 1998, Pediatric transplantation.

Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin.

S. Jordan, X. Zhang, M. Toyoda, 1994, Transplant immunology.

Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, gamma-IFN and IL-4) in vitro.

S. Jordan, M. Toyoda, E. Nicolaidou, 2001, Transplant immunology.

Study on lithium intercalation into MoS2

N. Imanishi, Y. Takeda, O. Yamamoto, 1992 .

A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients

M. Haas, S. Jordan, N. Reinsmoen, 2015, Transplantation.

Development of a real-time quantitative PCR assay for detection of a stable genomic region of BK virus

Jean F. Garcia-Gomez, Y. Iwaki, M. Toyoda, 2010, Virology Journal.

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

R. Busuttil, S. Jordan, S. McDiarmid, 1998, Transplantation.

Analysis of Subcutaneous (SQ) Alemtuzumab Induction Therapy in Highly Sensitized Patients Desensitized With IVIG and Rituximab

J. Wang, N. Reinsmoen, A. Vo, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of Induction Therapy Protocols on Transplant Outcomes in Crossmatch Positive Renal Allograft Recipients Desensitized with IVIG

A. Vo, M. Toyoda, S. Bunnapradist, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Adenovirus mediated IL-10 gene transfer to the airway of the rat lung for prevention of lung allograft rejection.

A. Marchevsky, J. Matloff, S. Jordan, 2006, Transplant immunology.

T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals

I. Pedraza, S. Jordan, Ruan Zhang, 2021, Cellular & Molecular Immunology.

Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy

L. Czer, S. Jordan, Paul L. Martin, 2006, Clinical Transplantation.

Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients

M. Haas, S. Jordan, N. Reinsmoen, 2014, Transplantation.

Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.

A. Sinha, S. Jordan, N. Reinsmoen, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.

S. Jordan, M. Toyoda, 1994, Clinical and experimental immunology.

Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.

S. Jordan, A. Vo, M. Toyoda, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.

L. Czer, X. Zhang, S. Jordan, 1997, Transplantation.

Outcome of management strategies for BK virus replication in pediatric renal transplant recipients

S. Jordan, M. Somers, A. Traum, 2008, Pediatric transplantation.

Ureteritis and cholecystitis: two unusual manifestations of cytomegalovirus disease in renal transplant recipients.

C. Nast, S. Jordan, M. Toyoda, 1997, Transplantation.

Assessment of Tocilizumab (Anti–Interleukin‐6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody‐Mediated Rejection and Transplant Glomerulopathy in HLA‐Sensitized Renal Allograft Recipients

M. Haas, A. Loupy, S. Jordan, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical significance of peripheral blood Epstein–Barr viral load monitoring using polymerase chain reaction in renal transplant recipients

S. Jordan, B. Warady, M. Toyoda, 2008, Pediatric transplantation.

Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.

Gordon D. Wu, S. Jordan, B. Shin, 2017, Transplantation.

Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy.

A. Bagga, C. Nast, S. Jordan, 2001, Kidney international.

HYDROPHOBIC EXTRACTS OF A CHINESE HERB (CMX-13) EXHIBIT POTENT IMMUNOSUPPRESSIVE PROPERTIES AND PREVENT ACUTE REJECTION IN A HIGHLY HISTOINCOMPATIBLE MODEL OF RAT LUNG TRANSPLANTATION1

S. Jordan, H. Yap, M. Toyoda, 2000, Transplantation.

Long-term allograft acceptance in a patient with posttransplant lymphoproliferative disorder: correlation with intragraft viral interleukin-10.

C. Nast, S. Jordan, M. Toyoda, 1997, Transplantation.

Immunosuppressive effect of the hydrophobic extract of a Chinese herb on rat lung allograft rejection.

A. Marchevsky, J. Matloff, S. Jordan, 1998, Transplantation proceedings.

Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients

E. Kamil, S. Jordan, J. Mirocha, 2017, Transplantation.

Treatment of Active Cytomegalovirus Disease with Oral Ganciclovir in Renal Allograft Recipients: Monitoring Efficacy with Quantitative Cytomegalovirus Polymerase Chain Reaction

E. Kamil, S. Jordan, A. Vo, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The role of novel therapeutic approaches for prevention of allosensitization and antibody‐mediated rejection

S. Jordan, Sanjeev Kumar, A. Vo, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Rituximab and intravenous immune globulin for desensitization during renal transplantation.

S. Jordan, N. Reinsmoen, A. Vo, 2008, The New England journal of medicine.

Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated Rejection

C. Nast, S. Jordan, Hao Zhang, 2017, Transplantation.

Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients

S. Jordan, Ruan Zhang, Sanjeev Kumar, 2021, Transplantation.

Treatment of Parvovirus B‐19 (PV B‐19) Infection Allows for Successful Kidney Transplantation Without Disease Recurrence

S. Jordan, A. Vo, M. Toyoda, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients

A. Vo, M. Toyoda, S. Jordan, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Co-infection of Polyomavirus-BK and Cytomegalovirus in Renal Transplant Recipients

S. Jordan, A. Vo, M. Toyoda, 2005, Transplantation.

Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin

S. Jordan, M. Toyoda, O. Galera, 1994, Journal of Clinical Immunology.

Desensitization: Overcoming the Immunologic Barriers to Transplantation

S. Jordan, A. Vo, M. Toyoda, 2017, Journal of immunology research.

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1

E. Kamil, S. Jordan, D. Tyan, 2003, Transplantation.

Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levels.

S. Jordan, S. Ge, A. Karasyov, 2010, Transplant immunology.

Selective expression of the interleukin-2 gene discriminates between the auto- and allo-mixed lymphocyte reaction.

S. Jordan, M. Toyoda, K. Galfayan, 1997, Transplant immunology.

Novel Therapeutic Approaches to Allosensitization and Antibody-mediated Rejection.

S. Jordan, A. Vo, M. Toyoda, 2019, Transplantation.

Imlifidase Inhibits HLA Antibody-Mediated NK Cell Activation and Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) In Vitro.

S. Jordan, S. Ge, A. Vo, 2019, Transplantation.

Tocilizumab (Anti-IL-6R) Suppressed TNFα Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular Cytotoxicity

S. Jordan, J. Mirocha, B. Shin, 2017, Transplantation direct.

Transient cold preservation alone stimulates tumor necrosis factor-alpha gene expression in a model of rat syngeneic lung transplantation.

A. Marchevsky, J. Matloff, S. Jordan, 2002, Transplantation proceedings.

Viral‐specific cytotoxic T‐cell responses in HLA‐sensitized kidney transplant patients maintained on everolimus and low‐dose tacrolimus

S. Jordan, Ruan Zhang, S. Ge, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Serum interleukin-2 levels in a patient with focal segmental glomerulosclerosis

U. Querfeld, S. Jordan, J. Prehn, 1990, Pediatric Nephrology.

Immunomodulatory Effects of Combination of Pooled Human Gammaglobulin and Rapamycin on Cell Proliferation and Apoptosis in the Mixed Lymphocyte Reaction

S. Jordan, M. Toyoda, A. Pao, 2004, Transplantation.

Intravenous immunoglobulin a natural regulator of immunity and inflammation.

S. Jordan, A. Vo, M. Toyoda, 2009, Transplantation.

Impact of Tocilizumab (Anti–IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection

S. Jordan, Hao Zhang, Xiaohai Zhang, 2020, Transplantation.

In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction.

S. Jordan, M. Toyoda, Nurmamet Amet, 2010, Transplant immunology.

CLAZAKIZUMAB (ANTI-IL-6) INDUCES FOXP3+ TREGS IN HIGHLY HLA SENSITIZED PATIENTS RECEIVING HLAI KIDNEY TRANSPLANTATION (NCT03380962)

S. Jordan, S. Ge, A. Vo, 2020 .

Cellular Immune Responses to Cytomegalovirus in Renal Transplant Recipients

S. Jordan, Raju Radha, Stanley Jordan, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia

R. Shane, S. Jordan, P. Zakowski, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antithrombin III treatment improves parameters of acute inflammation in a highly histoincompatible model of rat lung allograft rejection.

A. Marchevsky, J. Matloff, S. Jordan, 1999, Transplantation.

Interleukin 6: An Important Mediator of Allograft Injury.

Gordon D. Wu, S. Jordan, Sanjeev Kumar, 2020, Transplantation.

Interleukin 6: Pathogenic Potential and Therapeutic Approaches in Autoimmunity and Transplant Rejection

Gordon D. Wu, S. Jordan, A. Vo, 2018, eLS.

Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation

S. Jordan, A. Vo, M. Toyoda, 2011, Expert review of clinical immunology.

Extracorporeal Photopheresis (ECP) Improved Allograft Function and Significantly Reduced Inflammatory Cytokines in Patients (Pts) With Refractory Heart Allograft Dysfunction.: Abstract# 683

J. Kobashigawa, J. Patel, S. Jordan, 2014 .

Intravenous Immunoglobulin (IVIG) a Modulator of Immunity and Inflammation with Applications in Solid Organ Transplantation

S. Jordan, A. Vo, M. Toyoda, 2012 .

Expression of gamma-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients.

A. Bagga, S. Jordan, D. Ross, 1999, Clinical transplantation.

CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377)

S. Jordan, S. Ge, A. Vo, 2020 .

Differential soluble interleukin-2R levels in bilateral bronchoalveolar lavage after single lung transplantation.

A. Marchevsky, S. Nathan, S. Jordan, 1994, The Journal of Heart and Lung Transplantation.

Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.

Gordon D. Wu, S. Jordan, B. Shin, 2017, Transplantation.

Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan.

M. Kasuga, Y. Matsumoto, Y. Morita, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Immunologic monitoring of OKT3 induction therapy in cardiac allograft recipients.

L. Czer, S. Jordan, M. Toyoda, 1995, Clinical transplantation.

Inhibition of in vitro immunoglobulin production by a novel immunosuppressive drug brequinar sodium.

B. Jaffee, S. Jordan, D. Cramer, 1994, Transplantation science.

Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation.

R. Alsabeh, S. Jordan, A. Vo, 2002, Transplantation.

Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.

A. Sinha, S. Jordan, N. Reinsmoen, 2011, Clinical journal of the American Society of Nephrology : CJASN.